Endress+Hauser BioSense to develop equipment and methods for fast molecular analyses Weil am Rhein Increased safety in food production and other process applications is the declared aim of the joint venture between Endress+Hauser and Hahn-Schickard. To this end, both partners have established Endress+Hauser BioSense GmbH based in Freiburg, Germany. Its aim is to enable rapid, […]
TOKYO — OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has raised ¥800 million in Series B financing led by The University of Tokyo Edge Capital Partners (UTEC) with participation of ITOCHU Technology Ventures (ITV). OriCiro has also received a ¥200 million […]
TOKYO — OriCiroGenomics is a pioneer in cell-free DNA synthesis and amplification for genome-scale large-scale genetic therapy and synthetic biology. Today, the company announced that Shigemasa (“Shige”) Sasaki was appointed Chief Operating Officer/Chief Technology Officer and Nasir Kato Bashiruddin, Ph.D. as Chief Technology Officer. While Mr. Sasaki will be responsible for all aspects of the […]
Combination aims to transform the genomics landscape and deliver a differentiated product offering into high growth clinical markets Brings together Omniome’s high accuracy short-read sequencing platform, with PacBio’s market leading, high accuracy long-read solutions Transaction supported by concurrent $300 million PIPE financing from premier life science investors MENLO PARK, Calif. and SAN DIEGO — Pacific […]
Collaboration to develop production-scale HiFi Sequencing platform expected to Include technology from Omniome, Inc. Combining both highly accurate long and short read sequencing technologies expected to provide deeper clinical insights and lower the overall cost of analysis MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the creation of a new business unit, HTG Therapeutics. HTG plans to use this new drug discovery business unit to leverage its capabilities and expand upon the utility of the HTG EdgeSeq […]
Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the appointments of Brian Stolz as Chief People Officer, Diana King as Vice President of Customer Support, and Jordan Neysmith as Vice President of Engineering. The new leadership appointments follow the recent close of $276 million in Series C financing and support […]
Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers CARLSBAD, Calif. — Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T-cells and B-cells, which play a key role in the immune response system*. Using proprietary Ion AmpliSeq […]
Expanding initiative focused on next generation sequencing services tailored to research needs CORALVILLE, Iowa — Integrated DNA Technologies, Inc. (IDT), a leading comprehensive genomics research solutions provider, has added Predicine to the IDT Align Program. This move expands the program’s roster of preferred sequencing providers. The combination of IDT’s high quality and flexible next generation sequencing (NGS) […]
Celemics signs a supply agreement for BTSeq™ solution with Chinese Sanger sequencing service company
Celemics signs a supply agreement for BTSeq™ solution with Chinese Sanger sequencing service company – Celemics enters the Chinese DNA Sequencing market since its establishment – NGS-based BTSeq™ solution allows for highly accurate DNA sequencing with significantly reduced cost and time – The agreement scale is equivalent to 87% in celemics’ annual revenue Seoul, Korea: Celemics, […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
